Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand

Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings

(2021) Chonlaphat Sukasem et al.   Drug Metabolism and Pharmacokinetics

A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China

(2021) Chengxian Guo et al.   Frontiers in Pharmacology

Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and Phenytoin-Induced Cutaneous Adverse Drug Reactions in the South Indian Tamil Population

(2021) Shobana John et al.   Journal of Personalized Medicine

Association of carbamazepine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients

(2020) Francis Capule et al.   PHARMACOGENOMICS JOURNAL

Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics

(2020) Patompong Satapornpong et al.   Frontiers in Pharmacology

Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children

(2020) Wiparat Manuyakorn et al.   EPILEPSY RESEARCH

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update

(2020) Jason H. Karnes et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Association Between HLA Genotype and Cutaneous Adverse Reactions to Antiepileptic Drugs Among Epilepsy Patients in Northwest China

(2019) Xu Wang et al.   Frontiers in Neurology

Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population

(2019) Kavish Ihtisham et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms

(2019) Katherine C. Konvinse et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pharmacogenomics guidelines: Current status and future development

(2019) Chengxian Guo et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

HLA-B*13:01 as a Risk Allele for Antiepileptic Drugs-Induced Cutaneous Adverse Reactions: Higher Risk for Cross-Reactivity?

(2019) Fu-Li Min et al.   Frontiers in Neurology

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

(2018) Elizabeth J. Phillips et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature

(2018) Katharina Schwarze et al.   GENETICS IN MEDICINE

The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions

(2018) Wei-Ti Chen et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: A meta-analysis

(2018) Yilun Deng et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions

(2018) Wimonchat Tangamornsuksan et al.   JAMA Dermatology

Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population

(2017) Daniel F. Carr et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

HLA-A*24:02 as a common risk factor for antiepileptic drug–induced cutaneous adverse reactions

(2017) Yi-Wu Shi et al.   NEUROLOGY

Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries

(2017) Hazel Xiaohui Ang et al.   PHARMACOGENOMICS

Association of the HLA-B alleles with carbamazepine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype

(2017) Rika Yuliwulandari et al.   PHARMACOGENOMICS

HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis

(2017) Kanoot Jaruthamsophon et al.   Scientific Reports

Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles

(2017) Rebecca Pavlos et al.   Scientific Reports

Association of HLA genotypes with phenobarbital hypersensitivity in children

(2016) Wiparat Manuyakorn et al.   EPILEPSIA

Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population

(2016) Wichittra Tassaneeyakul et al.   Pharmacogenetics and Genomics

Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population

(2016) C-C Chang et al.   PHARMACOGENOMICS JOURNAL

The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population

(2015) Jangsup Moon et al.   EPILEPSIA

Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions

(2015) Thachanan Kongpan et al.   Pharmacogenetics and Genomics

Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions

(2014) Ursula Amstutz et al.   EPILEPSIA

HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis

(2014) Amy Hui-Ping Khor et al.   EPILEPSIA

Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population

(2014) Surasak Saokaew et al.   PLoS One

Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement

(2014) Mayumi Ueta et al.   Scientific Reports

Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population

(2013) Daniel F. Carr et al.   CLINICAL INFECTIOUS DISEASES

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing

(2013) S G Leckband et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genotype–phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations

(2013) Yi-Hsin Hsiao et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome

(2013) F.-R. Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Specific HLA types are associated with antiepileptic drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese subjects

(2013) Nahoko Kaniwa et al.   PHARMACOGENOMICS

Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing

(2012) M S Hershfield et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing

(2012) M A Martin et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs

(2012) Mei Liu et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

HLA-B Alleles and Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Han Chinese Population

(2011) Yi-Wu Shi et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Predicting adverse side effects of drugs

(2011) Liang-Chin Huang et al.   BMC GENOMICS

Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population

(2011) Choong-Chor Chang et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis

(2011) A. F. Cristallo et al.   International Journal of Immunogenetics

Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans

(2011) Hye-Ryun Kang et al.   Pharmacogenetics and Genomics

HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients

(2010) Nahoko Kaniwa et al.   EPILEPSIA

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population

(2010) Wichittra Tassaneeyakul et al.   EPILEPSIA

Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations

(2010) F. F. Gonzalez-Galarza et al.   NUCLEIC ACIDS RESEARCH

Common risk allele in aromatic antiepileptic-drug induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese

(2010) Shuen-Iu Hung et al.   PHARMACOGENOMICS

Applying the genome to national drug formulary policy in the developing world

(2010) Mary W Roederer et al.   PHARMACOGENOMICS

Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians

(2009) TimirY Mehta et al.   Indian Journal of Dermatology Venereology & Leprology

High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients

(2009) Gbenga R. Kazeem et al.   Pharmacogenetics and Genomics

Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

(2009) Wichittra Tassaneeyakul et al.   Pharmacogenetics and Genomics

High Sensitivity of Human Leukocyte Antigen–B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients

(2008) Michael Saag et al.   CLINICAL INFECTIOUS DISEASES

A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

(2008) Christine Lonjou et al.   Pharmacogenetics and Genomics

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis

(2008) Nahoko Kaniwa et al.   PHARMACOGENOMICS